Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382889024> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4382889024 endingPage "968" @default.
- W4382889024 startingPage "964" @default.
- W4382889024 abstract "Trastuzumab is a humanized monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) that is indicated for the treatment of HER2-positive breast cancer. The administration of biologics, such as trastuzumab, frequently causes infusion reactions (IRs) with fever and chills. This study aimed to clarify the risk factors for IRs in trastuzumab therapy. Between March 2013 and July 2022, 227 patients with breast cancer who started trastuzumab therapy were included in this study. The severity of IRs was graded according to the Common Terminology Criteria for Adverse Events, Version 5.0. The incidence of IRs in trastuzumab therapy was 27.3% (62/227). Dexamethasone administration was significantly different between the IR and non-IR groups in patients receiving trastuzumab therapy (univariate analysis, p < 0.001; multivariate analysis, p = 0.0002). Without dexamethasone, the severity of IRs in the pertuzumab combination group (Grade 1, 8/65; Grade 2, 23/65) was significantly higher than that in the non-pertuzumab group (Grade 1, 9/37; Grade 2, 3/37; p < 0.05). Our findings suggest that the risk of IRs is significantly higher in patients not premedicated with dexamethasone in trastuzumab therapy and that the concomitant use of pertuzumab without dexamethasone increases the severity of IRs caused by trastuzumab." @default.
- W4382889024 created "2023-07-03" @default.
- W4382889024 creator A5001307394 @default.
- W4382889024 creator A5013272243 @default.
- W4382889024 creator A5015364418 @default.
- W4382889024 creator A5021185843 @default.
- W4382889024 creator A5028364627 @default.
- W4382889024 creator A5035904712 @default.
- W4382889024 creator A5047647448 @default.
- W4382889024 creator A5055565453 @default.
- W4382889024 creator A5074543835 @default.
- W4382889024 date "2023-07-01" @default.
- W4382889024 modified "2023-10-16" @default.
- W4382889024 title "Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab Therapy" @default.
- W4382889024 cites W1980184027 @default.
- W4382889024 cites W2024651005 @default.
- W4382889024 cites W2097020324 @default.
- W4382889024 cites W2097483036 @default.
- W4382889024 cites W2097631809 @default.
- W4382889024 cites W2109921211 @default.
- W4382889024 cites W2111261737 @default.
- W4382889024 cites W2121960517 @default.
- W4382889024 cites W2150533624 @default.
- W4382889024 cites W2156677665 @default.
- W4382889024 cites W2165003903 @default.
- W4382889024 cites W2736017822 @default.
- W4382889024 cites W3211932483 @default.
- W4382889024 cites W4309409569 @default.
- W4382889024 doi "https://doi.org/10.1248/bpb.b23-00123" @default.
- W4382889024 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37394646" @default.
- W4382889024 hasPublicationYear "2023" @default.
- W4382889024 type Work @default.
- W4382889024 citedByCount "0" @default.
- W4382889024 crossrefType "journal-article" @default.
- W4382889024 hasAuthorship W4382889024A5001307394 @default.
- W4382889024 hasAuthorship W4382889024A5013272243 @default.
- W4382889024 hasAuthorship W4382889024A5015364418 @default.
- W4382889024 hasAuthorship W4382889024A5021185843 @default.
- W4382889024 hasAuthorship W4382889024A5028364627 @default.
- W4382889024 hasAuthorship W4382889024A5035904712 @default.
- W4382889024 hasAuthorship W4382889024A5047647448 @default.
- W4382889024 hasAuthorship W4382889024A5055565453 @default.
- W4382889024 hasAuthorship W4382889024A5074543835 @default.
- W4382889024 hasBestOaLocation W43828890241 @default.
- W4382889024 hasConcept C121608353 @default.
- W4382889024 hasConcept C126322002 @default.
- W4382889024 hasConcept C143998085 @default.
- W4382889024 hasConcept C2779384505 @default.
- W4382889024 hasConcept C2779786085 @default.
- W4382889024 hasConcept C2780401358 @default.
- W4382889024 hasConcept C2781164504 @default.
- W4382889024 hasConcept C530470458 @default.
- W4382889024 hasConcept C71924100 @default.
- W4382889024 hasConceptScore W4382889024C121608353 @default.
- W4382889024 hasConceptScore W4382889024C126322002 @default.
- W4382889024 hasConceptScore W4382889024C143998085 @default.
- W4382889024 hasConceptScore W4382889024C2779384505 @default.
- W4382889024 hasConceptScore W4382889024C2779786085 @default.
- W4382889024 hasConceptScore W4382889024C2780401358 @default.
- W4382889024 hasConceptScore W4382889024C2781164504 @default.
- W4382889024 hasConceptScore W4382889024C530470458 @default.
- W4382889024 hasConceptScore W4382889024C71924100 @default.
- W4382889024 hasIssue "7" @default.
- W4382889024 hasLocation W43828890241 @default.
- W4382889024 hasLocation W43828890242 @default.
- W4382889024 hasOpenAccess W4382889024 @default.
- W4382889024 hasPrimaryLocation W43828890241 @default.
- W4382889024 hasRelatedWork W2137228442 @default.
- W4382889024 hasRelatedWork W2343994751 @default.
- W4382889024 hasRelatedWork W2540085961 @default.
- W4382889024 hasRelatedWork W2760874931 @default.
- W4382889024 hasRelatedWork W2794565169 @default.
- W4382889024 hasRelatedWork W2994937700 @default.
- W4382889024 hasRelatedWork W3092390144 @default.
- W4382889024 hasRelatedWork W4206213581 @default.
- W4382889024 hasRelatedWork W4214767076 @default.
- W4382889024 hasRelatedWork W4322772378 @default.
- W4382889024 hasVolume "46" @default.
- W4382889024 isParatext "false" @default.
- W4382889024 isRetracted "false" @default.
- W4382889024 workType "article" @default.